Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Pharming Group N.V.

    NASDAQ: PHAR · Real-Time Price · USD
    10.75
    -0.81 (-7.05%)
    At close: Jun 13, 2025, 3:48 PM
    10.75
    0.01%
    After-hours: Jun 13, 2025, 04:00 PM EDT

    Pharming Statistics

    Share Statistics

    Pharming has 68.03M shares outstanding. The number of shares has increased by 0.73% in one year.

    Shares Outstanding

    n/a
    		 68.03M

    Shares Change (YoY)

    n/a
    		 0.73%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0.01%

    Shares Floating

    n/a
    		 65.16M

    Failed to Deliver (FTD) Shares

    n/a
    		 21

    FTD / Avg. Volume

    n/a
    		 0.57%

    Short Selling Information

    The latest short interest is 3.47K, so 0.01% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.47K

    Short % of Shares Out

    n/a
    		 0.01%

    Short % of Float

    n/a
    		 0.01%

    Short Ratio (days to cover)

    n/a
    		 2.14

    Valuation Ratios

    The PE ratio is -62.96 and the forward PE ratio is -113.9. Pharming's PEG ratio is -10.14.

    PE Ratio

    n/a
    		 -62.96

    Forward PE

    n/a
    		 -113.9

    PS Ratio

    n/a
    		 2.26

    Forward PS

    n/a
    		 1.8

    PB Ratio

    n/a
    		 3.13

    P/FCF Ratio

    n/a
    		 -258.67

    PEG Ratio

    n/a
    		 -10.14
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Pharming.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.51.

    Current Ratio

    n/a
    		 3.91

    Quick Ratio

    n/a
    		 3.15

    Debt / Equity

    n/a
    		 0.51

    Debt / EBITDA

    n/a
    		 15.08

    Debt / FCF

    n/a
    		 -41.84

    Interest Coverage

    n/a
    		 -0.95

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $735,643.56

    Profits Per Employee

    n/a
    		 $-26,347.43

    Employee Count

    n/a
    		 404

    Asset Turnover

    n/a
    		 0.77

    Inventory Turnover

    n/a
    		 0.66

    Taxes

    Income Tax

    n/a
    		 2.43M

    Effective Tax Rate

    n/a
    		 -29.53%

    Stock Price Statistics

    The stock price has increased by 25% in the last 52 weeks. The beta is 0.54, so Pharming's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.54

    52-Week Price Change

    n/a
    		 25%

    50-Day Moving Average

    n/a
    		 9.52

    200-Day Moving Average

    n/a
    		 8.8

    Relative Strength Index (RSI)

    n/a
    		 51.45

    Average Volume (20 Days)

    n/a
    		 3,671

    Income Statement

    In the last 12 months, Pharming had revenue of 297.2M and earned -10.64M in profits. Earnings per share was -0.15.

    Revenue

    n/a
    		 297.2M

    Gross Profit

    n/a
    		 252.72M

    Operating Income

    n/a
    		 -8.32M

    Net Income

    n/a
    		 -10.64M

    EBITDA

    n/a
    		 7.19M

    EBIT

    n/a
    		 245K

    Earnings Per Share (EPS)

    n/a
    		 -0.15
    Full Income Statement

    Balance Sheet

    The company has 53.04M in cash and 108.42M in debt, giving a net cash position of -55.38M.

    Cash & Cash Equivalents

    n/a
    		 53.04M

    Total Debt

    n/a
    		 108.42M

    Net Cash

    n/a
    		 -55.38M

    Retained Earnings

    n/a
    		 -265.36M

    Total Assets

    n/a
    		 403.18M

    Working Capital

    n/a
    		 136.57M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -1.79M and capital expenditures -796K, giving a free cash flow of -2.59M.

    Operating Cash Flow

    n/a
    		 -1.79M

    Capital Expenditures

    n/a
    		 -796K

    Free Cash Flow

    n/a
    		 -2.59M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross margin is 85.03%, with operating and profit margins of -2.8% and -3.58%.

    Gross Margin

    n/a
    		 85.03%

    Operating Margin

    n/a
    		 -2.8%

    Pretax Margin

    n/a
    		 -2.77%

    Profit Margin

    n/a
    		 -3.58%

    EBITDA Margin

    n/a
    		 2.42%

    EBIT Margin

    n/a
    		 -2.8%

    FCF Margin

    n/a
    		 -0.87%

    Dividends & Yields

    PHAR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PHAR is $37, which is 244.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $37

    Price Target Difference

    n/a
    		 244.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 2.5

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist